Ionis Pharmaceuticals's total assets for Q2 2025 were $2.99B, an increase of 6.12% from the previous quarter. IONS total liabilities were $2.35B for the fiscal quarter, a 0.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.